Trial Profile
An Observational,Multicenter,Cohort study evaluating impact of Telaprevir or Boceprevir on liver fibrosis in patients with Hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Nov 2016
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Boceprevir
- Indications Hepatitis C
- Focus Therapeutic Use
- 30 Nov 2016 New trial record